Democrats take aim at high drug prices with bill allowing Medicare to negotiate

WASHINGTON — The White House has been quick to claim credit for numerous drug companies’ decisions to back off planned price hikes for the remainder of 2018.

But such crowing from the Trump administration has not sat well with Democrats, who this week unveiled a pair of bills aimed at lowering prescription drug costs.

“I see little or nothing coming out of the Trump initiative,” Rep. Lloyd Doggett (D-Texas) said on a call with reporters on Tuesday. “That’s why we need new legislation.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In